Skip to main content
Clinical Trials/NCT05118581
NCT05118581
Unknown
Not Applicable

Safety and Efficacy of Ultrasound Guided Vascular Access

Sohag University0 sites100 target enrollmentDecember 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Vascular Access
Sponsor
Sohag University
Enrollment
100
Primary Endpoint
Incidence of adverse effects of ultrasound guided vascular access
Last Updated
4 years ago

Overview

Brief Summary

Vascular access involves central and peripheral vein accesses and arterial accesses. Central venous catheterization is widely used in clinical practice for diverse purposes, including hemodialysis for end stage renal failure, invasive hemodynamic monitoring, radiological studies, infusion of drugs that cannot be administered via peripheral vessels, administration of parenteral nutrition, vascular access in patients whose peripheral veins are difficult to be catheterized and for miscellaneous purposes that require access to large caliber vessels.

Arterial cannulation is used for invasive arterial pressure monitoring and to ensure access for diagnostic and therapeutic interventions.

In the United States and United Kingdom, guidelines have recommended the use of ultrasound guidance to reduce complications and improve success in central venous catheterization.

Registry
clinicaltrials.gov
Start Date
December 1, 2021
End Date
December 30, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mostafa Ahmed Elsayed

resident doctor at vascular surgery department sohag university hospital

Sohag University

Eligibility Criteria

Inclusion Criteria

  • · Adult patients who need vascular access (arterial or venous)

Exclusion Criteria

  • · Patients with local infection in the area targeted for vascular access.
  • Patients with severe generalized infection and other skin diseases or lesions.
  • patients with history of DVT of the target vein and or pulmonary embolism.
  • Patients with untreated coagulopathy (INR \>1.5 or platelets \<50000mm3)

Outcomes

Primary Outcomes

Incidence of adverse effects of ultrasound guided vascular access

Time Frame: one year

Number of participants with adverse effects after ultrasound guided vascular access

Similar Trials